Krystal Biotech, Inc. KRYS Interest Expense
Interest Expense at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s interest expense?
- Krystal Biotech, Inc. (KRYS) reported interest expense of $7.75M in Q1 2026.
- How has Krystal Biotech, Inc.'s interest expense changed year-over-year?
- Krystal Biotech, Inc.'s interest expense increased by 5.6% year-over-year, from $7.35M to $7.75M.
- What is the long-term trend for Krystal Biotech, Inc.'s interest expense?
- Over 3 years (2021 to 2025), Krystal Biotech, Inc.'s interest expense has grown at a 166.6% compound annual growth rate (CAGR), from $1.49M to $28.27M.
- What does interest expense mean?
- The cost of borrowing money, including interest on debt.
- How do you interpret interest expense?
- A decrease indicates reduced debt levels or lower interest rates, while an increase suggests higher leverage or rising borrowing costs.
- How does interest expense compare across companies?
- Standard metric for assessing financial health and debt service capacity across all capital-intensive industries.